Neurodegenerative disease treatment research receives early-stage funding at Wayne State University investment firm.

BIOTECH Patent News, August, 2006

Allied Minds (Boston MA), a pre-seed investment corporation specializing in early stage university business ventures, has partnered with Wayne State University (Detroit, MI) to establish a start-up company, GliaGen LLC which will specialize in novel diagnostic and therapeutic technologies specifically tailored to treat neurodegenerative diseases.

The newly formed GliaGen LLC has exclusively secured platform technology developed by Drs. Leon Carlock and Maria Cypher, of the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine. "These technologies provide new tools for understanding neural disease processes, as well as cellular repair mechanisms. This will significantly improve our ability to target these processes for diagnostic...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement